Anifrolumab can substantially lower the risk for long-term organ damage progression in patients with moderate to severe ...

In a new study, researchers explored experiences, perceptions, and health effects of a newly developed healthy lifestyle ...

New research suggests the use of oral prednisone should be limited in patients with systemic lupus erythematosus with a history of recurrent pericarditis.

More than one-third of patients with systemic lupus erythematosus experience a flare after starting dialysis for end-stage ...

A 2022 study found that just over 27% of people with systemic lupus erythematosus experience hearing loss, with 80% of cases being sensorineural hearing loss. This type of hearing loss usually ...

Systemic lupus erythematosus, or lupus, is a complex autoimmune disease in which the immune system mistakenly attacks healthy tissue, often affecting the skin, joints, kidneys and nervous system.

Assistant Professor Andrew Monteith's lab in the Department of Microbiology is documenting how key immune cells detect ...

At the time we did this, which was before 2012 when the Systemic Lupus Collaborating Clinics (SLICC) classification criteria came around, we used the 1997 revised [American College of Rheumatology ...

Conduit Pharmaceuticals reports advancements in lupus studies and trial designs. The Company partnered with Charles River ...

A common form of lupus is systemic lupus erythematosus. Systemic lupus erythematosus affects the whole body and can attack virtually any part of it, including skin, major organs, hair, muscles ...

The drug discovery pact between Charles River Laboratories, Valo Health and Flagship Pioneering is starting to bear fruit. | The drug discovery pact between Charles River Laboratories, Valo Health and ...